Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1. (Q40768927)

23 September 2017

title

Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1. (English)

1 reference

23 September 2017

0 references

Bès C

1

1 reference

23 September 2017

Briant-Longuet L

2

1 reference

23 September 2017

Cerruti M

3

1 reference

23 September 2017

De Berardinis P

4

1 reference

23 September 2017

Devauchelle G

5

1 reference

23 September 2017

Devaux C

6

1 reference

23 September 2017

Granier C

7

1 reference

23 September 2017

Chardès T

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

508

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

67-74

1 reference

The structure of the CD4 and CD8 genes

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Structure and expression of the human and mouse T4 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

CD4 augments the response of a T cell to agonist but not to antagonist ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Bioactive CD4 ligands as pre- and/or postbinding inhibitors of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Identification of a human CD4-CDR3-like surface involved in CD4+ T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Transduction of Activation Signal That Follows HIV-1 Binding to CD4 and CD4 Dimerization Involves the Immunoglobulin CDR3-like Region in Domain 1 of CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Increased anti-HIV-1 activity of CD4 CDR3-related synthetic peptides by scrambling and further structural modifications, including D-isomerization and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Phase II study of anti-CD4 idiotype vaccination in HIV positive volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

V beta-specific stimulation of human T cells by staphylococcal toxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The CD4 antigen: physiological ligand and HIV receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Identification of the residues in human CD4 critical for the binding of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Binding of CD4 ligands induces tyrosine phosphorylation of phosphatidylinositol-3 kinase p110 subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Ligands of CD4 inhibit the association of phospholipase Cgamma1 with phosphoinositide 3 kinase in T cells: regulation of this association by the phosphoinositide 3 kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Bound water molecules and conformational stabilization help mediate an antigen-antibody association

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Structure-based design of immunologically active therapeutic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Dimeric association and segmental variability in the structure of human CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Immunoglobulin superfamily proteins: structure, mechanisms, and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Characterization of a unique scrambled peptide derived from the CD4 CDR3-related region which shows substantial activity for blocking HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Peptide models of immunological recognition: paratope dissection by multiple peptide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Anti-CD4 therapy of acute rejection in long-term renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Anti-CD4 monoclonal antibody administration in renal transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Structural and Functional Properties of HIV-1(GER) TAR Sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

A comparison of the immunogenicity of a pair of enantiomeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Structural determinants in the sequences of immunoglobulin variable domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Antibody framework residues affecting the conformation of the hypervariable loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

Bioactive peptide design based on protein surface epitopes. A cyclic heptapeptide mimics CD4 domain 1 CC' loop and inhibits CD4 biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2801%2903036-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(01)03036-8

1 reference

release_jfhbkcgvijaglary6yuxt4knpa

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jfhbkcgvijaglary6yuxt4knpa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference